More News

27 Apr 2007 Royalty Pharma and InNexus Biotechnology Announce Agreement Regarding the Purchase of Royalty Rights Based on DXL(TM) Antibody Products
27 Apr 2007 Alchemia reports preliminary positive efficacy data from HyCAMP Phase II trial
26 Apr 2007 MediGene Completes Patient Recruitment for Clinical Phase II Trial of EndoTAG(R)-1
26 Apr 2007 Alkermes and Indevus Announce Initiation of Phase 2a Clinical Study of ALKS 27 for the Treatment of COPD
26 Apr 2007 Ranbaxy Receives Us Fda Approval To Manufacture And Market Pravastatin Sodium Tablets In Usa
26 Apr 2007 ADVENTRX Announces Positive Data From Preclinical Pharmacokinetic Testing of ANX-514 (Docetaxel Emulsion)
26 Apr 2007 BDSI Announces Positive Phase III Clinical Trial Results for BEMA(TM) Fentanyl
26 Apr 2007 Dr. Reddy's Announces the Launch of Zolpidem Tartrate Tablets
26 Apr 2007 OctoPlus obtains full rights to PolyActive drug delivery technology from IsoTis
25 Apr 2007 Beyond biogenerics: the real threats for therapeutic proteins
25 Apr 2007 Neuromed Licenses Phase 3 Chronic Pain Product from ALZA Corporation
25 Apr 2007 Neuromed Licenses Phase 3 Chronic Pain Product from ALZA Corporation
25 Apr 2007 Wockhardt receives US FDA approval for anti-hypertensive drug
25 Apr 2007 Sciele Pharma to Acquire Alliant Pharmaceuticals, a Pediatric Specialty Pharmaceutical Company
24 Apr 2007 AstraZeneca to acquire MedImmune for $58 per share in a fully recommended, all-cash transaction with a total enterprise value of $15.2 billion
24 Apr 2007 Alimera Sciences' Medidur(TM) Trial Exceeds 500 Patient Mark In Phase 3 Trial Enrollment
24 Apr 2007 Synosia Therapeutics Announces Second Major Pharmaceutical Deal
24 Apr 2007 KaloBios Licenses Humaneering(TM) Technology to Major Pharmaceutical Company
24 Apr 2007 Mylan Announces Final FDA Approval and Immediate Shipment of Zolpidem Tartrate Tablets
24 Apr 2007 Caraco Pharmaceutical Laboratories Ltd. Announces FDA Approval to Market Generic Ambien(R)
24 Apr 2007 Prasco Enters into Agreement with sanofi-aventis to Market the Authorized Generic Versions of Ambien(R) (Zolpidem Tartrate) CIV
24 Apr 2007 Vectura Announces Successful Outcome of Second Phase IIb Clinical Study on Inhaled Erectile Dysfunction Product
23 Apr 2007 AstraZeneca to Acquire MedImmune For $58 Per Share in a Fully Recommended, All-cash Transaction with a Total Enterprise Value of $15.2 Billion
21 Apr 2007 FDA Grants Full Approval for DepoCyt(R) for the Treatment of Lymphomatous Meningitis
21 Apr 2007 Baxter Presents Phase I Inhaled Insulin Study Results at Respiratory Drug Delivery Conference

La Merie Biologics

FREE Weekly News Bulletin

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing